When it comes to breast cancer screening and diagnosis, the faster and more accurate, the better.
Cooper University Health Care, a premier academic medical center in southern New Jersey, has taken a positive step toward fast and accurate care. Cooper Cancer Institute (CCI) recently added GE Healthcare’s SenoBright* Contrast Enhanced Spectral Mammography (CESM) technology for breast imaging. CCI will be the first in its region to offer SenoBright, helping physicians reach definitive diagnostic decisions.
SenoBright arms clinicians with a new tool to help detect and diagnose breast cancer rapidly and accurately, even in the densest part of the breast. With the technology, physicians are able to perform additional tests on the same Senographe mammography system, see the results in a familiar context, and make confident diagnostic decisions by providing a contrast-enhanced image in exactly the same position as the standard mammography views.
“This is a tremendous step forward in the diagnosis and treatment of breast cancer and Cooper is thrilled to be one of the first hospitals in the region to offer this remarkable technology,” said Kristin L. Brill, MD, Program Director of The Janet Knowles Breast Cancer Center at Cooper Cancer Institute and Director of the Section of Breast Surgery. “The SenoBright will increase patient satisfaction by relieving the burden of uncertainty through early diagnosis and as a result, will improve overall quality of care, productivity and patient access.”
SenoBright empowers clinicians to improve care pathways, increase efficiency, and control costs. GE estimates that by 2020, more than 1 million women worldwide will be examined using SenoBright and this will positively impact the diagnosis results for nearly 250,000 women.
* Trademark of General Electric Company